FDA
-
-
-
-
-
-
-
Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results
-
-
-
-
-
-
-
Accelerate Diagnostics Reports Preliminary First Quarter 2024 Financial Results
-
-
-
-
-
-
-
Accelerate Diagnostics Announces Launch of Proposed Public Offering
-
-
-
-
-
-
-
Accelerate Diagnostics Reports Second Quarter 2023 Financial Results
-
-
-
-
-
-
-
Accelerate Diagnostics scheduled call to review 2022 fourth quarter and full year results
-
-
-
-
-
-
-
Bragar Eagel & Squire, P.C. Is Investigating Establishment, Accelerate Diagnostics, Instil and Unisys and Encourages Investors to Contact the Firm
-
-
-
-
-
-
-
Accelerate Diagnostics (AXDX) Announces Commercialization of Accelerate Arc Module and BC Kit
-
322,868 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

